Xtalks — The Life Science Community™ brings together professionals across pharma, biotech, medtech, healthcare and research. Join our community today.

Online
Navigate the path from breakthrough science to global oncology execution with Catarina Ribeiro, MD, Alberto Puccini, MD, Martin Forster, MD, Paul Nathan, MBBS, PhD, FRCP and Joao Dias in this webinar hosted by Syneos Health. Oncology innovation is advancing rapidly, but sponsors must determine which scientific signals are development-ready and scalable across diverse populations, geographies and regulatory environments. The advantage lies in making earlier, evidence-led decisions that connect precision science to operationally viable global programs. Register for this webinar to learn how to strengthen proof-of-concept decisions, apply predictive intelligence effectively and scale complex oncology programs globally: xtalks.com/webinars/oncology… #SyneosHealth #Oncology #OncologyDrugDevelopment #ClinicalTrials #PrecisionMedicine #Biomarkers #ArtificialIntelligence #ClinicalDevelopment #DrugDevelopment #GlobalClinicalTrials #CancerResearch #Biopharma #LifeSciences
92
Navigate the challenge of measuring tau tangle pathology with Thomas Karikari, PhD and Dr. Tracy Liu, PhD in this webinar hosted by Spear Bio. As blood-based biomarker strategies mature, researchers need complementary tools that distinguish early amyloid-associated tau changes from pathology linked to neurofibrillary tangles and cognitive decline. Explore how ultrasensitive, wash-free immunoassays can measure low-abundance plasma eMTBR-Tau from just 1 µL of sample. Register for this webinar to learn how eMTBR-Tau differs from plasma pTau and supports tau tangle research, biomarker validation, and therapeutic development: xtalks.com/webinars/improve-… #SpearBio #AlzheimersDisease #TauBiomarkers #BloodBiomarkers #EMTBRTau #Neurodegeneration #BiomarkerResearch #ProteinDetection #Immunoassay #ClinicalResearch #DrugDevelopment #PrecisionMedicine #LifeSciences
253
Accelerate precision in neurodegeneration trial design with Bob Dagher, MD, Robin Wolz, PhD, Brian Murphy, PhD and Dr. Bill Byrom in this webinar hosted by Clinilabs. As CNS development becomes more data-driven, sponsors need objective measures that enable earlier detection, sharper patient stratification, and more confident treatment decisions. Biological, imaging, digital, and wearable biomarkers are redefining how trials measure progression and response. Register for this webinar to learn how biomarker strategies can optimize patient selection, trial design, and treatment monitoring for data-driven CNS development: xtalks.com/webinars/accelera… #Clinilabs #Neurodegeneration #CNSResearch #ClinicalTrials #Biomarkers #DigitalBiomarkers #WearableTechnology #DigitalHealth #AlzheimersDisease #ParkinsonsDisease #PrecisionMedicine #DrugDevelopment #ClinicalOperations #LifeSciences
184
Researchers are investigating VIP signaling as a potential immune checkpoint in cancer. Dr. Ned Waller of Cambium Oncology explains how the pathway may shape an immunosuppressive tumor microenvironment in pancreatic cancer and leukemia, including its effects across T cells, macrophages and cancer cells. Catch insights from the exclusive interview: xtalks.com/targeting-vip-sig… #CancerResearch #Immunotherapy #TumorMicroenvironment #PancreaticCancer #Leukemia
282
Noninvasive testing, fibrosis assessment and machine learning are changing how researchers think about MASH clinical trials. Dr. Winston Dunn of Summit Clinical Research Solutions and Pinnacle Clinical Research – San Antonio discusses patient screening, risk stratification and the growing need to match treatments to different patient profiles. Read the Xtalks Spotlight interview at xtalks.com/how-noninvasive-t… by @soumya2390. #CDMO #PharmaceuticalManufacturing #FacilityDesign #SterileManufacturing #Biopharma
202
Transform regulatory writing bottlenecks with Mark Pittman in this webinar hosted by ZyliQ.AI. Gen-AI is reshaping regulatory authoring, yet prompt engineering can create new inefficiencies and inconsistent outputs. Discover a content-driven approach that keeps medical writers focused on scientific judgment, review, and submission-ready quality within familiar workflows. Register for this webinar to learn how to reduce CSR first-draft time, map source content to regulatory documents, and work with Gen-AI directly in Microsoft Word: xtalks.com/webinars/accelera… #ZyliqAi #GenerativeAi #RegulatoryWriting #MedicalWriting #RegulatoryAffairs #LifeSciences #Biopharma #ClinicalDevelopment #ClinicalTrials #MicrosoftWord #ContentReuse #ArtificialIntelligence #DigitalTransformation
154
Navigate evolving cell and gene therapy access demands with Kim Tedesco, RPh and Dan Powell, PharmD, BCPS, CSP in this webinar hosted by Walgreens. As CGT pipelines move into broader indications and earlier treatment lines, access models must keep pace with more complex patient identification, referral, and care coordination requirements. The path to commercialization increasingly depends on translating precision medicine advances into scalable treatment pathways. Register for this webinar to learn how pipeline trends can shape access strategies, patient pathways, and commercialization readiness: xtalks.com/webinars/improve-… #Walgreens #CellAndGeneTherapy #GeneTherapy #CellTherapy #PrecisionMedicine #Biopharma #LifeSciences #PatientAccess #Commercialization #CareCoordination #PharmaStrategy #RareDisease #AdvancedTherapies
215
Day 2 at the OECT Summit is a done-done! @kpmorgangroup brought together a strong lineup of speakers tackling some of the biggest conversations shaping clinical trials today, from AI implementation and institutional authorization to patient voice, site engagement, recruitment and the human side of automation. It has been an exciting two days in Toronto, and we hope the discussions sparked here continue well beyond the summit and lead to even more conversations in the days and weeks ahead. This has been Xtalks On Location with Insiya, Mohammad and Stephanie. #OECTSummit #ClinicalTrials #ClinicalResearch #PatientEngagement #Xtalks
308
Flexible CDMO facilities need to support changing pipelines without adding unnecessary operational complexity. Jason R. Goodwin from @FUJIFILMBiotech discusses equipment selection, automation, vial filling and emerging gloveless technology. Get an exclusive peek from this Xtalks Spotlight interview at buff.ly/fpueQ7b by @soumya2390.
120
Navigate the market access implications of physician consolidation with Matthew Arnold, Dee Chaudhary, April Collins and Dana Jacoby in this webinar hosted by Clarivate. Physician supergroups are redefining care delivery, formulary influence and product adoption across key specialties. As independent practices scale through shared services, private equity and value-based care models, life sciences teams need sharper account intelligence and engagement strategies. Register for this webinar to learn how leading supergroups shape market growth, drug utilization and launch strategy: xtalks.com/webinars/the-rise… #Clarivate #LifeSciences #Biopharma #MarketAccess #PhysicianSupergroups #HealthcareConsolidation #ValueBasedCare #HealthcareData #CommercialStrategy #ProductLaunch #ProviderEngagement #HealthEconomics #PrecisionMedicine
135
Transform complex IVD study oversight with Jessica Green and Andrew Mercier in this webinar hosted by ARC Regulatory. IVD clinical performance studies demand stronger governance, cleaner data and faster decisions amid growing regulatory and operational complexity. Discover how sponsor delegation and hybrid monitoring can unite central oversight with targeted on-site support to reduce burden without compromising accountability. Register for this webinar to learn how hybrid monitoring can strengthen oversight, improve coordination and reduce operational risk in IVD clinical studies: xtalks.com/webinars/transfor… #ARCRegulatory #InVitroDiagnostics #IVD #ClinicalTrials #ClinicalOperations #HybridMonitoring #SponsorDelegation #RegulatoryAffairs #QualityManagement #ClinicalResearch #MedicalDevices #DiagnosticInnovation #RiskBasedMonitoring #LifeSciences
153
Meet Xtalks Featured Community Member Lorraine Dishman, Clinical Operations & Program Delivery Leader, Behind the Protocol™. Drawing on experience across site, CRO and academic settings, she focuses on turning complex clinical trial strategies into decisions teams can execute while keeping operational realities and patients in view. Read more: buff.ly/V5NOJ4G #ClinicalOperations #ClinicalResearch #ProgramDelivery #PatientCentricity #XtalksCommunity
208
Live from the 10th Annual OECT Summit in Toronto today, hosted by @KPMGLOBALS. The theme — From Prediction to Participation: Transforming Trial Success with AI. A question: is AI actually moving the needle on feasibility, trial operations and patient recruitment or is there still a gap between promise and practice? We’re here talking to speakers and listening for the themes that stand out. #OECkpm #ClinicalResearch #AIinClinicalResearch #LifeSciences #XtalksOnLocation
339
Xtalks is On Location today at the 10th Annual OECT Summit in Toronto, hosted by @KPMGLOBALS! Two days, a packed speaker lineup and one question running through much of the agenda: is AI actually delivering in clinical trials, or are we still chasing the hype? Today’s lineup is digging into where the real progress is, from smarter feasibility and site strategy to patient intelligence and AI-powered clinical operations, and where the gap between promise and practice still shows up. Proud to be media partners again this year. We’re speaking with clinical research leaders and following the conversations shaping clinical trials today. #OECkpm #ClinicalResearch #AIinClinicalResearch #ClinicalOperations #LifeSciences #XtalksOnLocation
190
Master clearer signal detection in MDD trials with Luka Lucić, PhD and Svenja Wacker, PhD in this webinar hosted by Cogstate. Placebo response can obscure treatment effects, but it is rarely driven by a single factor. Understand how trial design, endpoint quality, measurement practices, and operational variability can weaken drug-placebo separation. Register for this webinar to learn how to distinguish true and pseudo-placebo response, identify endpoint-quality risks, and apply targeted interventions to strengthen trial signal: xtalks.com/webinars/understa… #Cogstate #MajorDepressiveDisorder #MDDTrials #ClinicalTrials #PlaceboResponse #SignalDetection #ClinicalOperations #ClinicalOutcomeAssessments #EndpointQuality #PsychiatryResearch #CNSClinicalTrials #Biopharma #DrugDevelopment
168
Overcome cell and gene therapy characterization bottlenecks with Kirsty Maclean and Karthikeyan Devaraju in this webinar hosted by Cerba Research. As living drugs grow more complex, sponsors need integrated evidence of safety, identity, purity, potency, and sustained therapeutic activity across global programs. Discover how flow cytometry, genomics, and bioanalysis can connect molecular design to cellular function while supporting scalable, standardized development strategies. Register for this webinar to learn how multi-modality testing can strengthen CGT characterization, reduce translational risk, and support global trial execution: xtalks.com/webinars/bypassin… #CerbaResearch #CellAndGeneTherapy #CGT #CarT #StemCellTherapy #AAV #RNATherapeutics #FlowCytometry #Genomics #Bioanalysis #ClinicalDevelopment #TranslationalScience #Biopharma #ClinicalTrials
218
Transform AI productivity into measurable enterprise value with Shweta Singh Maniar, Gaurav Sharma and Akshat Jhaveri in this webinar hosted by Cognizant. AI adoption is accelerating across life sciences, but tool usage and local efficiency gains rarely translate into validated business outcomes. Discover the integration, operating-model, and measurement gaps that can quietly undermine AI ROI at enterprise scale. Register for this webinar to learn how to uncover hidden AI ROI barriers and measure impact beyond usage and perception: xtalks.com/webinars/the-prod… #Cognizant #LifeSciences #ArtificialIntelligence #GenerativeAI #AIROI #EnterpriseAI #DigitalTransformation #Biopharma #ClinicalOperations #HealthcareInnovation #DataStrategy #OperatingModel #BusinessValue #DigitalHealth
1
1
255